The main objective of the study is to comparatively assess the efficacy and tolerability of the drugs under study in the treatment of acute uncomplicated cystitis.
Urinary tract infections (UTI) are one of the most frequent reasons of surgery visits in Primary Care. More than 95 percent of UTIs are monomicrobial, although the microorganisms implied are varied, and the range of effective drugs could be extensive. The species most frequently isolated is Escherichia coli, with prevalence ranking between 85 and 90 percent of documented cases. E. coli has developed resistance to different antibiotics. Cefditoren is situated as a good candidate for the treatment of uncomplicated UTIs due to its spectrum of activity against E. coli. The study has been designed in accordance with the guidelines and recommendations in force to assess the efficacy of cefditoren pivoxil against ciprofloxacin, a drug which despite the increasing rate of resistance in some countries, continues to be a drug of choice for the treatment of uncomplicated UTIs.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
611
400 mg, oral, single dose during 3 days
250 mg, oral, twice a day for 3 days
General Hospital of Chest Disease of Athens
Athens, Greece
Microbiological efficacy
Time frame: 5-9 days post-therapy
Clinical efficacy
Time frame: 5-9 days post-therapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
General Hospital of Thessaloniki
Thessaloniki, Greece
CS Rincón de Loix
Benidorm, Alicante, Spain
CAP Cornella
Cornellà de Llobregat, Barcelona, Spain
CAP 17 setembre
el Prat de Llobregat, Barcelona, Spain
CAP Bartomeu Fabres Anglada
Gavà, Barcelona, Spain
CAP Amadeu Torner
L'Hospitalet de Llobregat, Barcelona, Spain
CAP Florida Nord
L'Hospitalet de Llobregat, Barcelona, Spain
CAP Dr. Vicens Papaceit
La Roca del Vallès, Barcelona, Spain
CAP Les Bases-Manresa 3
Manresa, Barcelona, Spain
...and 20 more locations